Study Stopped
Changes in practice patterns. From COVID-related disruptions to the adoption of ERAS protocols and robotic surgery, there was significant variability in standards of care making direct comparison between groups impractical.
Crural Dissection in Sleeve Gastrectomy
The Effect of Routine Crura Dissection in Sleeve Gastrectomy on Post-Operative Symptoms
1 other identifier
interventional
124
1 country
1
Brief Summary
The purpose of this study is to identify if there is a benefit in routine dissection of the diaphragmatic crura during sleeve gastrectomy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 15, 2019
CompletedFirst Posted
Study publicly available on registry
November 19, 2019
CompletedStudy Start
First participant enrolled
November 22, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 28, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 28, 2025
CompletedJune 3, 2025
May 1, 2025
5.5 years
November 15, 2019
May 28, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Change in Perioperative Symptoms as assessed by the Intermediate and Late-Post Operative Pain, Nausea and Dysphagia Questionnaire
The Intermediate and Late Post-Operative Pain, Nausea and Dysphagia Questionnaire is a 7-item questionnaire with scores ranging 0-40 with the higher score indicating severe symptoms.
Day 1, 12 months
Change in Perioperative Symptoms as assessed by the Rhodes Index of Nausea, Vomiting and Retching Questionnaire
The Rhodes Index of Nausea, Vomiting and Retching Questionnaire is an 8-item questionnaire with scores ranging from 0 to 32 with a higher score indicating increased symptoms of nausea.
Day 1, 12 months
Change in Perioperative Symptoms as assessed by the Gastroesophageal Reflux Disease-Questionnaire (GERD-Q)
The GERD-Q has a scoring range between 0-18 with a higher score indicating increased likelihood of GERD.
Baseline, 12 months
Change in Perioperative Symptoms as assessed by the Brief Esophageal Dysphagia Questionnaire (BEDQ)
The BEDQ has a scoring range between 0-40 with a higher score indicating increased symptoms of dysphagia.
Baseline, 12 months
Secondary Outcomes (1)
Correlation of the presence of hiatal hernias
Day 1
Study Arms (3)
Crura Dissection
EXPERIMENTALParticipants with a visually detectable hiatal hernia at the time of sleeve gastrectomy procedure will undergo a crura dissection and hiatal hernia repair.
National Practice
EXPERIMENTALParticipants with no detectable hiatal hernia will be randomized to either Group 2 or 3. Group 2 participants will be treated to the national practice patterns of complete dissection of the curvature of the stomach without dissection of the crura.
Standard of Care
EXPERIMENTALParticipants with no detectable hiatal hernia will be randomized to either Group 2 or 3. Group 3 participants will undergo the institutional standard of care with the dissection of the crura.
Interventions
The diaphragmatic crura, one of two tendon structures below the diaphragm, will be removed during the laparoscopic sleeve gastrectomy.
Surgical weight-loss procedure in which the stomach is reduced to about 15% of its original size, by surgical removal of a large portion of the stomach along the greater curvature.
This involves tightening the opening in your diaphragm with stitches to keep your stomach from bulging upward through the opening in the muscle wall.
Eligibility Criteria
You may qualify if:
- All patients undergoing primary sleeve gastrectomy at the University of Miami Division of Bariatric surgery
- Age between 18-69 years
- Able to provide consent
You may not qualify if:
- History of anti-reflux procedure
- History of foregut surgery
- Narcotic dependence
- History of gastroparesis
- Special/vulnerable populations such as minors, patients unable to consent, pregnant women, and prisoners will not be included in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Miami Medical Campus
Miami, Florida, 33136, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Nestor De La Cruz-Munoz, MD
University of Miami
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
November 15, 2019
First Posted
November 19, 2019
Study Start
November 22, 2019
Primary Completion
May 28, 2025
Study Completion
May 28, 2025
Last Updated
June 3, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share